It has been described that miR-125b could induce autophagy through its interaction with Foxp3 in thyroid cancer cells [69] and modulate autophagy in drug-resistant ovarian cancer cells using directly targeted MAP kinase interacting serine/threonine kinase 2 (MKNK2) [70]. Here, MKNK2 is linked to ovarian carcinoma.